Showing results (1-10 of 72) with videos related to
Sort By:
Pageof 8
Life Sciences|July 24, 2012
GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptorsPingwei Zhao, Mary E AboodPharmacology & Therapeutics|March 20, 2010
Pharmacological characterization of GPR55, a putative cannabinoid receptorHaleli Sharir, Mary E AboodMolecules (Basel, Switzerland)|September 10, 2021
CB1 Cannabinoid Receptor Signaling and Biased SignalingLuciana M Leo, Mary E AboodAdvances in Pharmacology (San Diego, Calif.)|August 23, 2017
CB1 and CB2 Receptor PharmacologyAllyn C Howlett, Mary E AboodBritish Journal of Pharmacology|July 2, 2010
The endocannabinoid system as a target for the treatment of neurodegenerative diseaseEmma L Scotter, Mary E Abood, Michelle GlassProgress in Neuro-Psychopharmacology & Biological Psychiatry|March 17, 2012
Cannabinoid receptors: nomenclature and pharmacological principlesLinda Console-Bram, Jahan Marcu, Mary E AboodMethods in Enzymology|July 29, 2017
Protocols and Good Operating Practices in the Study of Cannabinoid ReceptorsLinda M Console-Bram, Pingwei Zhao, Mary E AboodCannabis and Cannabinoid Research|June 30, 2017
CB1 allosteric modulator Org27569 is an antagonist/inverse agonist of ERK1/2 signalingThomas F Gamage, Johnathon C Anderson, Mary E AboodJournal of the National Cancer Institute. Monographs|December 1, 2021
Cannabinoid Cancer Biology and PreventionSean D McAllister, Mary E Abood, Joseph Califano, et al.Pageof 8